The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia
- PMID: 11207427
- DOI: 10.1016/s0891-0618(00)00109-5
The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia
Abstract
This paper is a review of a recent findings on the pathology of hippocampal interneurons in schizophrenia, with specific emphasis on a protein expressed by these cells, the alpha7-nicotinic acetylcholine receptor subunit. Convergent information indicates that interneurons in the hippocampus and other forebrain structures are decreased in number and function in subjects with schizophrenia. Among the neurochemical markers that are decreased in the hippocampus are synapsin I, cholecystokinin, somatostatin, glutamic acid decarboxylase, and nitric oxide synthase. GABA uptake sites and the GABA synthetic enzyme glutamic acid decarboxylase are also diminished. Included among these findings is decreased binding of alpha-bungarotoxin, which binds to low-affinity nicotinic acetylcholine receptors, such as the alpha7-nicotinic receptor. Co-labeling experiments in rodents indicate that these markers are expressed on overlapping populations of hippocampal interneurons. Thus, the finding of decreased neurochemical function of hippocampal interneurons is a widely replicated finding, with different groups reporting markedly similar findings using independent post mortem samples and different neurochemical strategies. Decreased alpha-bungarotoxin binding or decreased alpha7-nicotinic receptor immunoreactivity has also been found in the frontal cortex and in the nucleus reticularis thalami of schizophrenic subjects. The alpha7-nicotinic receptor subunit gene on chromosome 15q14 is a site of heritability for schizophrenia and bipolar affective disorder, and in, particular, for a deficit in inhibitory neuronal function associated with these illnesses. Thus, the post mortem data are further supported by psychophysiologic and genetic investigations that indicate a deficit in inhibitory interneuronal function, involving the alpha7-nicotinic receptor. The alpha7-receptor is a ligand-gated ion channel that admits calcium ions into cells, and it has been proposed to have various developmental roles. Its malfunction may be part of the developmental pathogenesis of schizophrenia.
Similar articles
-
alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons.J Neurophysiol. 2002 Jan;87(1):548-57. doi: 10.1152/jn.00316.2001. J Neurophysiol. 2002. PMID: 11784770
-
Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors.Neuroscience. 2001;106(1):55-67. doi: 10.1016/s0306-4522(01)00257-3. Neuroscience. 2001. PMID: 11564416
-
Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder.Bipolar Disord. 2011 Nov-Dec;13(7-8):701-7. doi: 10.1111/j.1399-5618.2011.00961.x. Bipolar Disord. 2011. PMID: 22085484
-
The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).Behav Brain Res. 2000 Aug;113(1-2):169-81. doi: 10.1016/s0166-4328(00)00211-4. Behav Brain Res. 2000. PMID: 10942043 Review.
-
Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia.Prog Neurobiol. 2010 Feb 9;90(2):263-75. doi: 10.1016/j.pneurobio.2009.10.008. Epub 2009 Oct 21. Prog Neurobiol. 2010. PMID: 19853005 Free PMC article. Review.
Cited by
-
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia.BMC Psychiatry. 2002 Jul 3;2:8. doi: 10.1186/1471-244x-2-8. BMC Psychiatry. 2002. PMID: 12095426 Free PMC article.
-
CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment.J Neural Transm (Vienna). 2018 Apr;125(4):741-748. doi: 10.1007/s00702-017-1833-5. Epub 2018 Jan 5. J Neural Transm (Vienna). 2018. PMID: 29305655
-
The role of nicotinic cholinergic neurotransmission in delusional thinking.NPJ Schizophr. 2020 Jun 12;6(1):16. doi: 10.1038/s41537-020-0105-9. NPJ Schizophr. 2020. PMID: 32532978 Free PMC article. Review.
-
High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.Brain Res Bull. 2015 Mar;112:35-41. doi: 10.1016/j.brainresbull.2015.01.008. Epub 2015 Jan 31. Brain Res Bull. 2015. PMID: 25647232 Free PMC article.
-
Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease.Int J Mol Sci. 2021 Apr 21;22(9):4299. doi: 10.3390/ijms22094299. Int J Mol Sci. 2021. PMID: 33919025 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical